Lisata Therapeutics's total assets for Q2 2024 were $42.57M, a decrease of -11.75% from the previous quarter. LSTA total liabilities were $4.58M for the fiscal quarter, a -16.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.